STAAR Surgical (STAA) Osake Kurssi

STAAR Surgical Co is primarily active in the medical device industry.

The main competitors of STAAR Surgical Co in the market include Alcon Inc., Johnson & Johnson Vision Care, Bausch Health Companies Inc., and Carl Zeiss Meditec AG.

STAAR Surgical Co is a renowned and influential company in the medical technology industry. Founded in 1982, STAAR Surgical Co specializes in manufacturing and distributing implantable lenses for the eye, especially for patients looking to correct vision problems such as cataracts. With a strong commitment to innovation and improving the lives of individuals with visual impairments, STAAR Surgical Co has established itself as a trusted market leader. Through its advanced product portfolio and dedication to research and development, STAAR Surgical Co continues to make significant contributions to the field of ophthalmology, positively impacting the lives of countless patients worldwide.

STAAR Surgical Co has achieved several significant milestones. In recent years, the company has experienced significant growth and expanded its global presence. STAAR Surgical Co introduced innovative products and technologies, such as its next-generation intraocular lenses, which have revolutionized the treatment of cataracts and other vision disorders. The company's breakthrough products have garnered numerous accolades and received regulatory approvals in major markets worldwide. STAAR Surgical Co has also formed strategic partnerships and collaborations to advance its research and development efforts. These achievements highlight the company's commitment to providing innovative and effective vision solutions, solidifying its position as a leading global ophthalmic medical device company.

STAAR Surgical Co is primarily present in multiple countries and regions across the globe. With its headquarters in Monrovia, California, the company has established a strong presence in key markets. STAAR Surgical Co operates in the United States, where it serves a significant customer base. Additionally, the company has expanded its reach to other regions, including Europe, Asia, and Latin America. By diversifying its geographic footprint, STAAR Surgical Co aims to cater to a global audience and deliver its innovative ophthalmic products and solutions to healthcare professionals and patients worldwide.

STAAR Surgical Co represents values of innovation, quality, and patient-centric approach in the field of ophthalmic medical devices. As a leading provider of implantable lenses for cataract and refractive surgery, STAAR Surgical Co is committed to improving and restoring vision for individuals globally. The company's corporate philosophy revolves around delivering safe, effective, and technologically advanced products that address the diverse needs of eye care professionals and patients. With a focus on research and development, STAAR Surgical Co strives to enhance visual outcomes, improve quality of life, and provide sustainable solutions in the constantly evolving field of ophthalmology.

Analyytikot asettavat tällä hetkellä STAAR Surgical-osakkeelle keskimääräisen tavoitehinnan 31,50 USD (mediaani: 31,50 USD), mikä merkitsee +28,4 % viimeisimpään hintaan verrattuna. Konsensus perustuu 16 analyytikkoarvioon.

STAAR Surgical Analyytikkojen kursstavoitteet 2026

16 analyytikkoa arvioi tällä hetkellä STAAR Surgical-osaketta: 8 suosittaa ostoa, 7 pitoa ja 1 myyntiä. Vuodelle 2026 analyytikot odottavat STAAR Surgical-yhtiöltä 334,34 M USD liikevaihtoa ja 0,29 USD osakekohtaista tulosta.

STAAR Surgical Analyytikkojen kursstavoitteet 2026

Nykyisellä valuuttakurssilla STAAR Surgical-osake noteerataan hintaan 21,99 EUR (24,54 USD).

STAAR Surgical-osake (STAA) on listattuna 5 pörssissä, muun muassa: NASDAQ (STAA), SIX (Zürich) (SR3.SW), Frankfurt (SR3.F), München (SR3.MU), Düsseldorf (SR3.DU).

STAAR Surgical Co is a leading provider of products for ophthalmology and cosmetic surgery. The company is headquartered in California, USA and has been operating in the industry for over 30 years. It offers innovative implants and instruments for the treatment of vision disorders and eye diseases. The business model of STAAR Surgical Co is based on various segments: the main focus is on the manufacturing of implantable lenses for the correction of vision disorders such as myopia (nearsightedness) and hyperopia (farsightedness). The implants are typically used during surgery and can result in the patient being able to see without glasses or contact lenses. There are different variations of these lenses, such as toric lenses, which also allow for astigmatism correction, or the multifocal ICL lens, a newer generation of lenses that allows for particularly good visual acuity at both close and far distances. Another segment of STAAR Surgical Co is cosmetic surgery. The company supplies instruments and devices, particularly for eyelid surgery and eyebrow correction, which are used in plastic and aesthetic surgery. The goal is to improve the visual appearance of the eye area, reduce swelling, or correct unwanted cosmetic flaws. Another important business area of the company is research and development of new technologies and methods. STAAR Surgical Co continuously invests in research and innovation to improve product quality and develop new technologies. The company works closely with leading scientists, doctors, and professionals, and relies on the latest technologies and advanced manufacturing methods. STAAR Surgical Co generates a large portion of its revenue in global markets. The products are delivered to more than 75 countries, with the main market being the USA. The company operates its own production facilities in Switzerland and Singapore, as well as a network of distribution and marketing partners to ensure fast and smooth delivery to customers. To better serve its customers, the company also offers training and education. These are offered in specialized training centers that focus on ophthalmology and aesthetic surgery. Here, doctors and surgeons can learn about new developments and techniques to stay up to date. Overall, the business model of STAAR Surgical Co combines expertise, innovation, and quality. With a focus on ophthalmology and cosmetic surgery, the company delivers valuable products and services to meet the needs of patients and surgeons. STAAR Surgical Co continues to strive to establish itself and expand its market share by continuously expanding its product and service portfolio and investing in research and development. Answer: STAAR Surgical Co is a leading provider of products for ophthalmology and cosmetic surgery. It offers innovative implants and instruments for vision disorders and eye diseases. The company's business model is based on manufacturing implantable lenses for vision correction and supplying instruments for cosmetic surgery. It also focuses on research and development to improve product quality and develops new technologies. STAAR Surgical Co operates globally, with the main market being the USA. It provides training and education in specialized centers. The company aims to expand its market share by continuously expanding its product and service portfolio and investing in research and development.

odotettu liikevaihto STAAR Surgical on 334,34 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto STAAR Surgical on 14,45 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

STAAR Surgical:n hinta-voitto-suhde (P/E) on tällä hetkellä 84,17. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan STAAR Surgical-osakkeen arvostusta.

STAAR Surgical:n hinta-myynti-suhde (P/S) on tällä hetkellä 3,64. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii STAAR Surgical-osakkeen arvostuskennuslukuna.

STAAR Surgical:n Eulpool-laatuscore on 4/10.

STAAR Surgical:n ISIN on US8523123052. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

STAAR Surgical:n WKN on 870353. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

STAAR Surgical:n ticker on STAA. Tämä pörssinoteeraus käytetään STAAR Surgical-osakkeiden kauppaan pörssissä.